Exchange: Other OTC Industry: Drug Manufacturers
-9.80% $5.80
America/New_York / 3 feb 2023 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 61.51 mill |
EPS: | 0 |
P/E: | 0 |
Earnings Date: | May 18, 2022 |
SharesOutstanding: | 10.61 mill |
Avg Daily Volume: | 58.17 mill |
RATING 2023-02-03 |
---|
B+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Neutral | |
DE: | Strong Buy | |
P/E: | Neutral | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/21 | 3/21 | 4/21 | 1/22 | 2/22 | 3/22 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 0 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 0 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
$6.34 (9.28%) $0.538 |
Date: 2023-02-05 |
Expected Trading Range (DAY) |
---|
$ 4.40 - 7.20 ( +/- 24.12%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-12-19 | Siokas Grigorios | Buy | 260 870 | Warrants |
2022-12-19 | Siokas Grigorios | Buy | 260 870 | Common Stock, $.001 par value |
2022-12-02 | Siokas Grigorios | Sell | 703 | Series A Preferred Stock |
2022-12-02 | Siokas Grigorios | Buy | 1 131 098 | Common Stock, $.001 par value |
2022-11-30 | Siokas Grigorios | Sell | 299 | Series A Preferred Stock |
INSIDER POWER |
---|
91.89 |
Last 100 transactions |
Buy: 50 641 125 | Sell: 3 011 681 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $5.80 (-9.80% ) |
Volume | 1.313 mill |
Avg. Vol. | 58.17 mill |
% of Avg. Vol | 2.26 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|